Xenon Pharmaceuticals Inc. - Common Shares (XENE) analyst actions
Rating and price-target actions on XENE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the XENE overview →
No XENE analyst action events in the measured window.
Nothing matched in the current window — the XENE overview has every event we measure for this name.
Get an email when XENE moves on news →Keep exploring
More XENE: earnings → · SEC filings → · XENE overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Aclaris Therapeutics, Inc. (ACRS) | 275 | 0.00% | 48% |
| Anika Therapeutics Inc. (ANIK) | 275 | +0.07% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.